BridgeMD
Tests treatment safety and results for Femoracetabular Impingement
Official title Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy
ClinicalTrials.gov ID: NCT07037888
What this study is testing
What is Ketorolac?
Ketorolac is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for femoracetabular impingement.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to learn whether the medication ketorolac can help manage pain after hip arthroscopy as well or better than the standard opioid-based pain medications. This study focuses on adult patients (over 18 years old) undergoing hip arthroscopy at Henry Ford Health System in Detroit, Michigan.
- Phase 4: studies an already-approved treatment
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 89
You may be able to join if
- Patients undergoing hip arthroscopy over the age of 18 with Dr. T. Sean Lynch
- Diagnosis of femoroacetabular impingement (FAI)
You likely can't join if
- Patients with inability to consent and/or do not speak English
- Patients with conditions contraindicated with NSAIDs (medication allergy, peptic ulcer disease, bleeding diathesis, and renal disease)
- Patients with history of drug and alcohol use disorder
- Patients with chronic analgesia (filled two opioid prescriptions within 6 months of the surgery)
- Patients with psychotropic medication usage
- Patients who take pentoxifylline, probonecid, aspirin, and/or NSAIDs who cannot stop taking it for the study
See the full eligibility criteria
- Patients undergoing hip arthroscopy over the age of 18 with Dr. T. Sean Lynch
- Diagnosis of femoroacetabular impingement (FAI)
- Patients with inability to consent and/or do not speak English
- Patients with conditions contraindicated with NSAIDs (medication allergy, peptic ulcer disease, bleeding diathesis, and renal disease)
- Patients with history of drug and alcohol use disorder
- Patients with chronic analgesia (filled two opioid prescriptions within 6 months of the surgery)
- Patients with psychotropic medication usage
- Patients who take pentoxifylline, probonecid, aspirin, and/or NSAIDs who cannot stop taking it for the study
- Patients who are not discharged same day after surgery
The study team makes the final eligibility decision.
Where it's taking place
- Detroit, Michigan, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 89 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Detroit, Michigan, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.